RadNet, Inc.
General ticker "RDNT" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $5.1B (TTM average)
RadNet, Inc. follows the US Stock Market performance with the rate: 0.1%.
Estimated limits based on current volatility of 3.1%: low 59.28$, high 63.03$
Factors to consider:
- Total employees count: 11264 (+31.8%) as of 2025
- US accounted for 98.5% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Economic downturns and volatility, Inflationary pressures, Pandemic risks, Cybersecurity threats, Acquisition/divestiture risks
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [60.95$, 94.29$]
- 2026-12-31 to 2027-12-31 estimated range: [59.99$, 94.43$]
Financial Metrics affecting the RDNT estimates:
- Negative: with PPE of 186.8 at the end of fiscal year the price was high
- Positive: 19.19 < Shareholder equity ratio, % of 29.00 <= 42.57
- Positive: Industry inventory ratio change (median), % of 0.10 <= 0.28
- Positive: Interest expense per share per price, % of 1.28 <= 3.34
- Positive: -5.34 < Operating profit margin, % of 3.04
- Positive: Inventory ratio change, % of -0.18 <= 0
- Positive: -0.03 < Operating cash flow per share per price, % of 5.46
- Negative: negative Industry operating income (median)
Short-term RDNT quotes
Long-term RDNT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,626.11MM | $1,824.91MM | $2,021.99MM |
| Operating Expenses | $1,527.41MM | $1,720.29MM | $1,960.00MM |
| Operating Income | $98.70MM | $104.62MM | $61.99MM |
| Non-Operating Income | $-59.89MM | $-59.76MM | $-30.08MM |
| Interest Expense | $64.48MM | $79.85MM | $69.91MM |
| Income(Loss) | $38.81MM | $44.86MM | $31.91MM |
| Taxes | $8.47MM | $6.03MM | $-14.86MM |
| Net Income(Loss)* | $3.04MM | $2.79MM | $-18.65MM |
| Stockholders Equity | $630.70MM | $902.31MM | $1,089.89MM |
| Assets | $2,690.47MM | $3,286.69MM | $3,758.56MM |
| Operating Cash Flow | $220.86MM | $233.02MM | $298.82MM |
| Capital expenditure | $176.60MM | $188.07MM | $213.25MM |
| Investing Cash Flow | $-201.47MM | $-233.07MM | $-343.87MM |
| Financing Cash Flow | $195.63MM | $397.95MM | $72.21MM |
| Earnings Per Share** | $0.05 | $0.04 | $-0.25 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.